PMID: 8997178Dec 1, 1996Paper

Mechanisms of inhibition of insulin release

The American Journal of Physiology
G W Sharp

Abstract

Several agonists including norepinephrine, somatostatin, galanin, and prostaglandins inhibit insulin release. The inhibition is sensitive to pertussis toxin, indicating the involvement of heterotrimeric Gi and/or Go proteins. Receptors for the different agonists have different selectivity for these G proteins. After G protein activation, the alpha- and beta gamma-subunits dissociate and interact with multiple targets to inhibit release. These include 1) the ATP-sensitive K+ channel and perhaps other K+ channels, 2) L-type voltage-dependent Ca2+ channels, 3) adenylyl cyclase, and 4) a "distal" site late in stimulus-secretion coupling. The latter effect, which may be exerted close to the final stage of exocytosis, is the most powerful of the individual inhibitory mechanisms. G protein action on the target molecules is determined by the individual G proteins activated and their specificity for the targets. The L-type Ca2+ channel is inhibited by G(o)-1. Adenylyl cyclase is inhibited by Gi-2 and Gi-3. The distal inhibition can be exerted by Gi-1, Gi-2, Gi-3, and G(o)-2. Thus there is both selectivity and promiscuity in G protein action in the beta-cell. These characteristics allow an inhibitory ligand to be effective at multiple ta...Continue Reading

References

Aug 6, 1992·European Journal of Pharmacology·D Hillaire-BuysM M Loubatières-Mariani
Aug 1, 1992·The Journal of Endocrinology·C M GrondaJ J Gagliardino
Oct 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·F R HomaidanL M Nowak
Nov 19, 1991·European Journal of Pharmacology·S Lindskog, B Ahrén
Jan 1, 1992·Endocrinology·M KomatsuT Yamada
Sep 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·S MislerM L McDaniel
Feb 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J de WeilleM Lazdunski
Apr 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·J R de WeilleM Lazdunski
Jul 1, 1985·Cell Biochemistry and Function·P C MathiasW J Malaisse
May 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·D J DruckerJ F Habener
Oct 1, 1968·Endocrinology·A GulbenkianI I Tabachnick
Nov 7, 1995·Proceedings of the National Academy of Sciences of the United States of America·M KomatsuG W Sharp
Mar 31, 1993·Biochemical and Biophysical Research Communications·T Fridolf, B Ahrén

❮ Previous
Next ❯

Citations

Jan 14, 2003·Experimental Biology and Medicine·Malathi SrinivasanMulchand S Patel
Aug 20, 2003·European Journal of Clinical Investigation·J C HenquinP Gilon
Sep 10, 2003·Endocrinology·Linda Ste Marie, Richard D Palmiter
Sep 27, 2005·Physiological Reviews·Susumu Seino, Tadao Shibasaki
Jan 18, 2007·American Journal of Physiology. Endocrinology and Metabolism·Paul MitraniMulchand S Patel
Dec 14, 2006·American Journal of Physiology. Endocrinology and Metabolism·Paul MitraniMulchand S Patel
Dec 22, 2007·The Journal of Biological Chemistry·Michelle E KimplePatrick J Casey
Dec 20, 2011·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Vladimír Strbák
Apr 12, 2012·American Journal of Physiology. Cell Physiology·Susanne G Straub, Geoffrey W G Sharp
Sep 10, 2014·Diabetes, Obesity & Metabolism·T ShibasakiS Seino
Jun 19, 2019·Physical Biology·Taegeun Song, Junghyo Jo
Feb 3, 1999·Annals of the New York Academy of Sciences·S EmamiG Rosselin
Nov 18, 2000·The Journal of Physiology·P Maechler, C B Wollheim
Apr 6, 2002·British Journal of Pharmacology·Anne VirsolvyDominique Bataille
Aug 14, 2001·American Journal of Physiology. Endocrinology and Metabolism·R AalinkeelM S Patel
Nov 30, 2000·American Journal of Physiology. Endocrinology and Metabolism·M SrinivasanM S Patel
Sep 18, 2002·The Journal of Pharmacology and Experimental Therapeutics·Rajesh AminAnjaneyulu Kowluru
Aug 1, 2007·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Paul E HarrisAntonella Maffei
Feb 10, 2007·The Journal of Biological Chemistry·Gerhard M SchmidJean-Charles Sanchez
Oct 28, 2006·Drugs & Aging·Alain DuclosStuart M Flechner
Jan 14, 2011·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Ismail SyedAnjaneyulu Kowluru
Jul 4, 2013·Molecular Endocrinology·Eric M WausonMelanie H Cobb
Nov 21, 2013·American Journal of Physiology. Endocrinology and Metabolism·Xiaochuan ChenSean W Limesand
Sep 8, 2017·Diabetes, Obesity & Metabolism·Anjaneyulu Kowluru
May 23, 1998·Annual Review of Pharmacology and Toxicology·R J Miller
Aug 27, 2005·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Zuzana BacováVladimir Strbák
Nov 24, 2006·American Journal of Physiology. Endocrinology and Metabolism·Haiying ChengGeoffrey W G Sharp
Nov 14, 2003·American Journal of Physiology. Endocrinology and Metabolism·Andrea SiegSusanne Ullrich

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.